Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000771277 | SCV000903426 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000771277 | SCV002536359 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-28 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV000771277 | SCV002682557 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-09-21 | criteria provided, single submitter | clinical testing | The p.G289D variant (also known as c.866G>A), located in coding exon 4 of the MSH6 gene, results from a G to A substitution at nucleotide position 866. The glycine at codon 289 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is well conserved through mammals but not in all available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003594029 | SCV004254337 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-05-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001358402 | SCV005201220 | uncertain significance | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23621914, 22290698, 28767289, 21437237, 27997549, 16010685, 26898890, 32659497, 26689913, 26580448, 29684080, 18269114) |
Department of Pathology and Laboratory Medicine, |
RCV001358402 | SCV001554122 | uncertain significance | not provided | no assertion criteria provided | clinical testing |